Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

laboratory biomarker analysis (2)

berzosertib (1)

cetuximab (1)

cisplatin (1)

lenalidomide (1)

radiation therapy (1)

Study Documents

Intervention Type

drug (2)

other (2)

biological (1)

radiation (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

stage ivc oropharyngeal squamous cell carcinoma ajcc v7

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell

Active, not recruiting

Head and Neck Carcinoma of Unknown Primary
+19 more

Berzosertib
+3 more

Duarte, California
+18 more

Aug 24, 2022

Recurrent Colon Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma Trial

Completed

Recurrent Colon Carcinoma
+41 more

Cetuximab
+2 more

Columbus, Ohio

Ohio State University Comprehensive Cancer Center

Mar 12, 2020